72,234 articles
Lipid nanoparticle-mediated base editor delivery
Lipid nanoparticle-mediated base editor delivery is a non-viral method that uses lipid particles to deliver base-editing mRNA and guide RNA into cells, mainly in the liver.
Lipid profile
Lipid profile (lipid panel): blood test measuring total cholesterol, HDL-C, and triglycerides, with calculated LDL-C and non-HDL-C, used for ASCVD risk screening; non-fasting sampling is now standard, with Martin/Hopkins or Sampson equations preferred over Friedewald.
Lipid–calcium–phosphate nanoparticles
Lipid–calcium–phosphate (LCP) nanoparticles are core–shell drug delivery particles with a calcium phosphate core wrapped in a lipid shell, developed in Leaf Huang's laboratory as an improvement on the earlier LPD formulation.
Lipid–polymer hybrid nanoparticles
Lipid–polymer hybrid nanoparticles (LPHNPs, also called LPNs or PLNs) are core–shell drug-delivery nanostructures, typically 50–200 nm, that pair a biodegradable polymer core with a lipid or lipid–PEG shell.
Lipidomics
Lipidomics is the analysis of lipid composition, structure, and changes in biological samples such as cells, tissues, or body fluids, most often by mass spectrometry and nuclear magnetic resonance spectroscopy.
Lipika Goyal
Lipika Goyal is an American medical oncologist who directs the Gastrointestinal Oncology program at the Stanford Cancer Institute, known for leading the 2023 futibatinib trial in bile duct cancer.
Lipinski's rule of five
Lipinski's rule of five (Ro5) is a medicinal chemistry guideline for oral drug-likeness: MW ≤500 Da, clogP <5, ≤5 H-bond donors, ≤10 acceptors, from Lipinski et al. 1997; extended by Veber and Ghose rules and challenged by beyond-Ro5 drugs.
Lipizzan
Lipizzan (Lipizzaner, Lipicanec): Habsburg horse breed founded 1580 at Lipica from Spanish horses and Karst mares; gray coat via STX17, six classical stallion lines, Spanish Riding School mount, bred at eleven European state studs.
Lipoabdominoplasty
Lipoabdominoplasty is a body-contouring operation combining liposuction with abdominoplasty, introduced by Saldanha in 2001; selective undermining preserves blood and lymphatic vessels, giving fewer complications than conventional abdominoplasty.
Lipoatrophy or lipodystrophy
Lipoatrophy or lipodystrophy is a term for rare disorders in which the body loses, or fails to develop, adipose tissue, leading to insulin resistance and diabetes.
Lipoblastoma
Lipoblastoma, also called lipoblastomatosis in its diffuse form, is a rare benign pediatric soft tissue tumor of fetal fat with PLAG1 (8q11-q13) rearrangements, treated by complete excision with about 17% pooled recurrence.
Lipocalin
Lipocalins are small extracellular beta-barrel proteins binding hydrophobic ligands, found in all kingdoms except Archaea; 19 human members include RBP4 and NGAL, an acute kidney injury biomarker.
Lipocalin-2
Lipocalin-2, also known as neutrophil gelatinase-associated lipocalin (NGAL), is a protein of innate immunity and one of the earliest biomarkers of acute kidney injury, rising within 2–4 hours.
Lipodermatosclerosis
Lipodermatosclerosis, also called sclerosing panniculitis or hypodermitis sclerodermaformis, is a chronic inflammatory leg condition with subcutaneous fibrosis and skin hardening caused by venous insufficiency, featuring acute cellulitis-like and chronic inverted champagne bottle phases.
Lipodystrophy
Lipodystrophy: rare disorders of selective body-fat loss, genetic (CGL, FPLD; AGPAT2, BSCL2, LMNA genes) or acquired (AGL, APL, HIV-related), causing insulin resistance, diabetes, hypertriglyceridemia; treated with diet, metreleptin, statins.
Lipogenesis
Lipogenesis (de novo lipogenesis, DNL): synthesis of fatty acids from acetyl-CoA and their esterification to triglycerides, mainly in liver and adipose tissue; stimulated by carbohydrate and insulin, inhibited by fasting, PUFA, leptin, and growth hormone.
Lipoic acid biosynthesis
Lipoic acid biosynthesis is the enzymatic pathway that builds the lipoyl cofactor on its target enzymes, using octanoate from fatty acid synthesis and inserting sulfur via the radical SAM enzyme LipA.
Lipoid pneumonitis
Lipoid pneumonitis (lipoid pneumonia): rare lung inflammation from lipid buildup in alveoli; exogenous form from aspirated or inhaled oils (mineral oil, vaping products), endogenous (cholesterol) form from airway obstruction; diagnosed by fat attenuation on CT.
Lipoid proteinosis
Lipoid proteinosis (Urbach-Wiethe disease, hyalinosis cutis et mucosae) is a rare autosomal recessive genodermatosis from ECM1 mutations, causing hoarse cry from infancy, beaded eyelid papules, waxy scarring skin, and amygdala calcifications.
Lipolysis
Lipolysis is the enzymatic breakdown of stored triglycerides into fatty acids and glycerol, driven by ATGL, HSL, and MGL and regulated by catecholamines, insulin, and natriuretic peptides.
Lipoma
Lipoma: a common benign tumor of mature fat cells forming a soft, movable subcutaneous lump, usually in adults 40-60; painless and rarely treated, distinguished from liposarcoma by slow growth.
Lipophagy
Lipophagy is the selective autophagic degradation of lipid droplets in lysosomes, discovered in 2009; it fuels mitochondrial β-oxidation, is regulated by AMPK–mTORC1–TFEB, and its dysfunction contributes to fatty liver disease, atherosclerosis, and cancer.
Lipopolysaccharide
Lipopolysaccharide (LPS, endotoxin) is the glycolipid of the Gram-negative bacterial outer membrane, built from lipid A, core oligosaccharide, and O antigen; lipid A activates innate immunity via the TLR4–MD-2 complex and can trigger septic shock.
Lipopolysaccharide core heptose(I) kinase RfaP
WaaP, also called RfaP (EC 2.7.1.235), is a bacterial kinase that phosphorylates heptose I of the LPS inner core in E. coli, Salmonella, and Pseudomonas, stabilizing the outer membrane; essential in P. aeruginosa and an antimicrobial drug target.
Lipopolysaccharide core heptose(II) kinase
WaaY (waaY, rfaY, b3625) is the E. coli lipopolysaccharide core heptose(II) kinase, an ATP-dependent inner-core kinase that phosphorylates HepII after WaaP and WaaQ, affecting LL-37 susceptibility.
Lipoprotein
Lipoprotein: spherical lipid–protein particle (chylomicrons, VLDL, IDL, LDL, HDL, Lp(a)) with hydrophobic core and amphipathic apolipoprotein surface that transports cholesterol and triglycerides in blood; density classes, LDL receptor uptake, reverse cholesterol transport, and 2025–2026 guideline targets.
Lipoprotein insulin resistance index
The lipoprotein insulin resistance (LP-IR or LPIR) index is a blood test score, from 0 to 100, that estimates insulin resistance from six NMR-measured lipoprotein parameters.
Lipoprotein lipase
Lipoprotein lipase (LPL), endothelial enzyme hydrolyzing triglycerides in chylomicrons and VLDL; requires apo C-II and GPIHBP1; inhibited by ANGPTL3/4/8; deficiency causes familial chylomicronemia syndrome.
Lipoptena cervi
Lipoptena cervi, the deer ked (Pediculus cervi, Linnaeus 1758), is a wing-shedding hippoboscid fly parasitizing cervids, especially moose; Palearctic, spread to North America, bites humans, and carries detected zoonotic pathogens.
Liposarcoma
Liposarcoma, a malignant soft tissue sarcoma of fat cells in adults, includes well-differentiated, dedifferentiated, myxoid, and pleomorphic subtypes with MDM2/CDK4 12q amplification and highly subtype-dependent survival.